Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
- Posted on October 30, 2024
- By CNBC
- 2 Views
Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
We're upgrading our rating on the drugmaker to a buy-equivalent 1.
